Cancer Diagnostics Market: Advances in Technology and Favorable Government Initiatives to Aid the Global Market
The global market for cancer diagnostics has been displaying a highly competitive vendor landscape on account of the presence of a number of established players, reports a new research study by Transparency Market Research (TMR). The main players operating in this market are Eli Lilly and Co., GlaxoSmithKline Plc, Genoptix Inc., bioMerieux, Pfizer, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Novartis, Ambry Genetics, and AstraZeneca. These companies are focusing aggressively on strategic collaborations and mergers and acquisitions to expand their reach...
View full press release